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Abstract
Objective: The study aims to identify risk constellations for symptomatic spinal cord malperfusion in patients undergoing extensive stent-
graft coverage of the thoracic aorta. Methods: From 1997 through 2009, 26 patients (mean age 70 years) underwent extensive stent-graft
coverage of the thoracic aorta. Indications for stent-graft placement were atherosclerotic aneurysms (n = 18) and penetrating atherosclerotic
ulcers (PAUs) (n = 8). In 16 patients, a re-routing procedure was required to gain sufficient proximal landing zone length. Cerebrospinal fluid
(CSF) drainage was not routinely applied owing to the necessity of maintaining continuing anti-platelet therapy due to severe cardiovascular
co-morbidities. Results: Technical success was 100%. Five patients developed symptomatic spinal cord malperfusion. All symptomatic
patients had impaired spinal cord blood supply by acute or chronic occlusion of at least two major blood-supplying vascular territories of the
spinal cord. Secondary CSF drainage improved neurologic symptoms in all patients without causing any anti-platelet therapy-related
collateral injury. Conclusions: Extensive stent-graft coverage of the entire thoracic aorta can be performed with a high rate of success.
If collateral blood supply to the spinal cord is maintained, occlusion of the intercostal arteries does not cause symptomatic malperfusion.
However, if acute or chronic occlusion of the subclavian, lumbar or hypogastric arteries is present, likelihood of symptomatic malperfusion
dramatically increases.
# 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
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Stent-graft placement in aortic pathology requiring
coverage of the entire thoracic aorta is performed in an
increasing number of patients. Recent work has shown that
coverage of longer segments is directly related to a higher
incidence of neurologic complications [1]. However, to date,
the literature focusses merely on intercostal arteries but not
on the complex entity of the collateral network of the major
spinal cord supplying vessels [2].
The aim of this study was to identify risk constellations
for symptomatic spinal cord malperfusion in patients
undergoing extensive stent-graft coverage of the thoracic§ Presented at the 23rd Annual Meeting of the European Association for
Cardio-thoracic Surgery, Vienna, Austria, October 18—21, 2009.
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supply.
2. Patients and methods
Between 1996 and 2009 at our department, 277 patients
underwent endovascular stent-graft placement due to
thoracic aortic diseases. Twenty-six patients with a disease
extent requiring stent-graft coverage of the entire thoracic
aorta from the aortic arch to the coeliac trunk were included
into this study. The institutional review board approved the
study and waived the need for patient consent.
All patients had substantial co-morbidities. Patient demo-
graphics are shown in Table 1. All patients underwent risk
stratification according to the European system for cardiac
operative risk evaluation (EuroSCORE) guidelines [3]. Euro-
SCORE is known as an extensive preoperative risk stratification
system comprising demographic, cardiac-related as well as
surgery-related variables. Both additive and logistic values
were collected as logistic EuroSCOREhas been reported to bea
better risk predictor in high-risk patients [4].Surgery. Published by Elsevier B.V. All rights reserved.
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Table 1
Demographics
Mean age 70 (57—82) years
Male/female 18/8
Underlying pathology
Thoracic aortic aneurysm 18
Penetrating atherosclerotic ulcer 8
Co-morbidities
CAD 13 (50%)
COPD 16 (61%)
Hypertension 24 (92%)
PAD 5 (19%)
Renal insufficiency 4 (15%)
Diabetes 6 (23%)
Previous MCI 5 (19%)
Previous aortic procedures
Abdominal aorta 6 (23%)
Ascending aorta 3 (11%)
EuroSCORE
Numeric EuroSCORE 10.9 (7—15)
Logistic EuroSCORE 31.5 (10.6—64.0)
CAD — coronary artery disease — defined as morphological correlate in coro-
nary angiography.
COPD — chronic obstructive pulmonary disease — defined as long-term use of
bronchodilators or steroids for lung disease.
Hypertension — defined as requirement of chronic medical therapy tomaintain
normotonic blood pressure profiles.
PAD — peripheral artery disease — defined as clinical or morphological proven
impairment of peripheral blood supply.
Renal insufficiency — defined as serum creatinine 2 mg/dl in repeated
measurements.
Diabetes — defined as requirement of therapy to maintain normal blood sugar
levels.
Previous myocardial infarction — defined as enzyme infarction with morpho-
logical or functional correlate in coronary angiography or echocardiography.2.1. Preoperative evaluation, landing zones and surgical
approach
Preoperative evaluation was done by multislice computed
tomography (CT) scans to evaluate the aorto-iliac axis for
later arterial access for stent-graft insertion. These CT scans
were also carefully reviewed for critical stenoses or
occlusions of the vessels that form the collateral network
as an alternate blood supply of the spinal cord [5,6].
Furthermore, these CTscans were used as a tool to predict
the required length of the intended proximal landing zone. As
a prerequisite for successful stent-graft placement, a
proximal landing zone of at least 2.0 cm was claimed. If
preoperative evaluation revealed disease extent into the
aortic arch, re-routing procedures were applied to gain
sufficient landing zone. After re-routing, an additional CT
scan was performed to reconfirm the effective length of the
intended landing zone extension.
2.2. Re-routing procedures
In three patients, a subclavian-to-carotid transposition
was required to gain a sufficient landing zone; in 10 patients,
a double transposition was required while three patients
required total arch re-routing. The original methods have
been described in detail previously [7—10]. Re-routing
procedures were performedmetachronously. Median intervalbetween supra-aortic transposition and stent-graft place-
ment was 7 days. In one patient who presented with
contained aortic rupture, the subclavian artery was over-
stented owing to paucity of time to perform a preceding
subclavian-to-carotid transposition.
2.3. Stent-graft systems used
Four different commercially available stent-graft sys-
tems were used. The Talent and, after having been
modified, the Valiant endovascular stent grafts (Medtronic
Inc., Santa Rosa, CA, USA) were used in seven patients. The
Relay stent graft (Bolton Medical, Sunrise, FL, USA) was
used in eight patients. The Gore Excluder or TAG stent graft
(W.L. Gore & Associates, Flagstaff, AZ, USA) was used in 11
patients. For all systems, the diameter of the stent graft
was calculated from the largest diameter of the proximal
or distal neck, and an oversizing factor of 10—20% was
added.
2.4. Stent-graft placement
Stent-graft placement was performed under general
anaesthesia. In 16 patients, a transfemoral approach was
chosen. If the diameter of the external iliac artery was not
sufficient, the common iliac artery was used for arterial
access (n = 8). Stent-graft deployment was routinely per-
formed under hypotonic conditions (80 mmHg systolic
pressure).
2.5. Definition of endoleaks
Endoleaks were defined according to the reporting
standards [11]. Type I endoleaks were defined as attachment
site leaks, type Ia at the proximal attachment site and type Ib
at the distal attachment site. Type II endoleaks were defined
as branch leaks without attachment site connection. Type III
endoleaks were defined as junctional leaks between stent
grafts if more than one graft was used. Persistent endoleak
rate was defined as the rate of endoleaks persisting after
watchful waiting, balloon dilatation or additional stent-graft
placement.
2.6. Postoperative management
For early detection of spinal cord malperfusion, patients
were extubated immediately after stent-graft placement or,
if extubation was not possible due to poor pulmonary
function, sedation was superficialised to allow neurologic
evaluation. In addition, mean arterial pressure was kept
above 80 mmHg for the first 96 h to prevent spinal cord
hypoperfusion.
2.7. Cerebrospinal fluid drainage
Cerebrospinal fluid (CSF) drainage was not routinely
applied because of the necessity of maintaining continuous
anti-platelet therapy due to severe cardiovascular co-
morbidities. If neurologic symptoms occurred, CSF drainage
was installed immediately.
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Table 2
Patent vessels for collateral spinal cord blood supply — preoperative.
Subclavian artery Intercostal arteries Lumbar arteries Left hypogastric artery Right hypogastric artery
Patient 1 + + S S S
Patient 2 + S S + +
Patient 3 + + S + +
Patient 4 S + S + +
Patient 5 + + S + +
(+) Open vessels, (S) occluded vessels.
Table 3
Patent vessels for collateral spinal cord blood supply — postoperative.
Subclavian artery Intercostal arteries Lumbar arteries Left hypogastric artery Right hypogastric artery
Patient 1 + S S S S
Patient 2 + S S + +
Patient 3 + S S + +
Patient 4 S S S + +
Patient 5 + S S S- +
(+) Open vessels, (S) occluded vessels.2.8. Follow-up protocol
Patients were followed up according to a strict protocol
that required a contrast spiral CT scan and clinical as well
as laboratory evaluation at 3, 6 and 12 months after
surgery, and then annually thereafter. Magnetic resonance
angiography was used alternatively when chronic renal
insufficiency or allergy to iodinated contrast were
detected. Additional investigations were obtained when-
ever indicated.
3. Results
3.1. Surgical results
All supra-aortic transpositions were performed success-
fully. One patient required concomitant aortic valve
replacement due to severe aortic valve stenosis. One patient
underwent elective splenectomy due to an isolated offspring
of the lienal artery within the intended landing zone to
prevent potential lienal malperfusion and necrosis.
3.2. Stent-graft placement and concomitant procedures
Stent-graft placement was successfully performed in all
patients. A mean of 2.8 prostheses was used. In four
patients additional vascular procedures were concomi-
tantly performed (infrarenal bifurcation stent-graft place-
ment, n = 1, iliacofemoral bypass, n = 2, femoral patch
plasty, n = 1).
3.3. In-hospital morbidity and mortality
Two patients required prolonged intubation due to
respiratory failure. In one patient, bleeding at the access
site had to be treated. One patient (4%) died 2 days after
stent-graft placement due to myocardial infarction. One
patient developed a lymphatic fistula in the groin.3.4. Adverse neurologic events and collateral spinal cord
supply
Preoperative evaluation of collateral blood supply showed
occlusion of one or more vascular beds responsible for
collateral blood supply in eight patients. In one patient the
left subclavian artery was occluded, the intercostal arteries in
one, the lumbar arteries in six patients, the left hypogastric
artery in one and both hypogastric arteries in two patients. In
five patients, paraparesis was observed within an interval of
3—48 h after stent-graft placement. As a consequence CSF
drainage was installed, leading to resolution of symptoms in
four patients. The remaining patient showed improvement of
symptomswith enduring weakness of the left lower extremity.
All five patients had impaired collateral spinal cord blood
supply by acute or chronic occlusion of at least two major
supplying vascular territories. Table 2 shows spinal cord blood
supply before stent-graft placement and Table 3 after stent-
graft placement. Three of these patients had undergone prior
infrarenal replacement due to atherosclerotic aneurysms.One
patient underwent concomitant infrarenal bifurcation stent-
graft placement for bilateral iliac aneurysms. Despite
continuing anti-platelet therapy, insertion of CSF drainage
did not result in any kind of bleeding complications.
3.5. Endoleaks, need for re-interventions and survival
The rate of assisted primary types I and III endoleak was
8%. Two late type Ia endoleaks were observed. One patient
was treated successfully. The mean follow-up period was 25
months, ranging from 3 to 81 months. During follow-up, nine
patients died whereas just one aortic-related death was
observed.
4. Discussion
Extensive stent-graft coverage of the entire thoracic
aorta can be performed with a high rate of success. If
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occlusion of the intercostal arteries does not cause sympto-
matic malperfusion. However, if acute or chronic occlusion of
the subclavian, lumbar or hypogastric arteries is present,
likelihood of symptomatic malperfusion dramatically
increases.
Supra-aortic transpositions are now an established
procedure for extending the proximal landing zone to enable
stent-graft placement [7—9]. In our setting, this method is
used extensively as short- and mid-term results have shown
excellent patency as well as no increase in procedural risk as
compared with isolated descending stent-graft placement
[10]. Furthermore, supra-aortic transpositions can be safely
combined with routine open-cardiac procedures such as
aortic valve replacement in our setting.
Mean number of stent grafts was high, reflecting the long
covered segments to effectively exclude the underlying
aortic pathology. The risk of type III endoleak formation due
to decreased lateral stability of stent grafts is directly
correlated with the number of prostheses [12]. However, this
fact could not be observed in this series, as extensive
overlapping between prostheses was applied. In patients
with an underlying dilatative arteriopathy, access vessels
normally are large enough to advance the delivery system by
femoral access. In patients with an underlying obliterative
arteriopathy such as penetrating atherosclerotic ulcer (PAU),
a side graft to the common iliac artery must be chosen in a
large number of patients due to narrowing of the external
iliac artery. As in our setting, this graft may be extended to
the groin as an illiaco-femoral bypass in order to concomi-
tantly treat symptomatic peripheral artery disease.
Recent investigations newly defined the functional
anatomy of spinal cord blood supply. Against the long-
standing doctrine that the major spinal cord blood-supplying
vessel is located at the thoraco-abdominal transition,
experimental and clinical work have shown that the spinal
cord blood supply is supported by a complex network of
several contributing major vascular territories [13—15].
The main contributors, besides intercostal arteries, are
the subclavian, lumbar and hypogastric arteries [5,6].
Interestingly, spinal cord injury after thoracic stent-graft
placement is lower than after conventional aortic surgery.
[16] Potential explanations are based in the maintenance of
normotonic blood pressure during stent-graft placement as
well as the lack of steal phenomena [17,18]. Furthermore,
due to the limited surgical exposition, homeostasis in these
physiologically frail patients is better preserved. However,
as other vascular territories may be affected by the
underlying disease, the collateral network may be impaired
by acute or chronic occlusion of major supplying vessels.
When applying this hypothesis to our neurologically
symptomatic patient cohort we could clearly demonstrate
that this concept is of clinical relevance. All patients
suffering from symptomatic spinal cord malperfusion had
occlusion of two or more major supplying vessels, including
the intended occlusion of intercostal arteries by stent-graft
placement (Tables 2 and 3).
CSF drainage is a useful means of lowering pressure in the
spinal canal thereby improving spinal cord perfusion in both
open and endovascular thoracic aortic repair. Absence of any
ongoing anticoagulation therapy is a prerequisite for electiveCSF drainage insertion [19]. As many patients depend on
continuing anti-platelet therapy due to severe concomitant
disease, such as those after drug-eluting stent implantation,
the risk—benefit ratio of withdrawing the anti-platelet
therapy may be excessively high. Therefore, CSF drainage
is not routinely applied in these patients in our setting. As
shown, secondary insertion can be performed without
subjecting this group of patients to additional risk.
In summary, extensive stent-graft coverage of the entire
thoracic aorta can be performedwith a high rate of success. If
collateral blood supply to the spinal cord is maintained,
occlusion of the intercostal arteries does not cause sympto-
matic malperfusion. However, if acute or chronic occlusion of
either the subclavian, lumbar or hypogastric arteries is
present, the likelihood of symptomatic malperfusion dra-
matically increases.
References
[1] Gravereaux EC, Faries PL, Burks JA, Latessa V, Spielvogel D, Hollier LH,
Marin ML. Risk of spinal cord ischemia after endograft repair of thoracic
aortic aneurysms. J Vasc Surg 2001;34:997—1003.
[2] Kawaharada N, Morishita K, Kurimoto Y, Hyodoh H, Ito T, Harada R, Kuwaki
K, Higami T. Spinal cord ischemia after elective endovascular stent-graft
repair of the thoracic aorta. Eur J Cardiothorac Surg 2007;31:998—1003.
[3] Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R.
European system for cardiac operative risk evaluation (EuroSCORE). Eur J
Cardiothorac Surg 1999;16:9—13.
[4] Michel P, Roques F, Nashef SA, EuroSCORE Project Group. Logistic or
additive EuroSCORE for high-risk patients. Eur J Cardiothorac Surg
2003;23:684—7.
[5] Lazorthes G, Gouaze A, Zadeh JO, Santini JJ, Lazorthes Y, Burdin P.
Arterial vascularisation of the spinal cord. Recent studies of the anatomic
substitution pathways. J Neurosurg 1971;253—62.
[6] Biglioli P, Roberto M, Cannata A, Parolari A, Fumero A, Grillo F, Maggioni
M, Coggi G, Spirito R. Upper and lower spinal cord supply: the continuity
of the anterior spinal artery and the relevance of the lumbar arteries. J
Thorac Cardiovasc Surg 2004;127:1188—92.
[7] Czerny M, Fleck T, Zimpfer D, Dworschak M, Hofmann W, Hutschala D,
Dunkler D, Ehrlich M, Wolner E, Grabenwoger M. Combined repair of an
aortic arch aneurysm by sequential transposition of the supraaortic
branches and consecutive endovascular stent graft placement. J Thorac
Cardiovasc Surg 2003;126:1296—301.
[8] Gottardi R, Seitelberger R, Zimpfer D, Lammer J, Wolner E, Grimm M,
Czerny M. An alternative approach in treating an aortic arch aneurysm
with an anatomic variant by supraaortic reconstruction and stent graft
placement. J Vasc Surg 2005;42:357—60.
[9] Czerny M, Zimpfer D, Fleck T, Hofmann W, Schoder M, Cejna M, Stampfl P,
Lammer J, Wolner E, Grabenwoger M. Initial results after combined repair
of aortic arch aneurysms by sequential transposition of the supra-aortic
branches and consecutive endovascular stent graft placement. Ann
Thorac Surg 2004;78:1256—60.
[10] Gottardi R, Funovics M, Eggers N, Hirner A, Dorfmeister M, Holfeld J,
Zimpfer D, Schoder M, Donas K, Weigang E, Lammer J, Grimm M, Czerny
M. Supra-aortic transposition for combined vascular and endovascular
repair of aortic arch pathology. Ann Thorac Surg 2008;86:1524—9.
[11] Chaikof EL, Blankensteijn JD, Harris PL, White GH, Zarins CK, Bernhard
VM, Matsumura JS, May J, Veith FJ, Fillinger MF, Rutherford RB, Kent KC,
Ad Hoc Committee for Standardized Reporting Practices in Vascular
Surgery of The Society for Vascular Surgery/American Association for
Vascular Surgery. Reporting standards for endovascular aortic aneurysm
repair. J Vasc Surg 2002;35:1048—60.
[12] Czerny M, Grimm M, Zimpfer D, Rodler S, Gottardi R, Hutschala D,
Lammer J, Wolner E, Schoder M. Results after endovascular stent graft
placement in atherosclerotic aneurysms involving the descending aorta.
Ann Thorac Surg 2007;83:450—5.
[13] Griepp RB, Griepp EB. Spinal cord perfusion and protection during
descending thoracic and thoracoabdominal aortic surgery: the collateral
network concept. Ann Thorac Surg 2007;83:S865—9.
R. Gottardi et al. / European Journal of Cardio-thoracic Surgery 37 (2010) 1081—1085 1085[14] Etz CD, Halstead JC, Spielvogel D, Shahani R, Lazala R, Homann TM,Weisz
DJ, Plestis K, Griepp RB. Thoracic and thoracoabdominal aneurysm
repair: is reimplantation of spinal cord arteries a waste of time? Ann
Thorac Surg 2006;82:1670—7.
[15] Etz CD, Homann TM, Plestis KA, Zhang N, Luehr M, Weisz DJ, Kleinman G,
Griepp RB. Spinal cord perfusion after extensive segmental artery sacri-
fice: can paraplegia be prevented? Eur J Cardiothorac Surg 2007;31:
643—8.
[16] Walsh SR, Tang TY, Sadat U, Naik J, Gaunt ME, Boyle JR, Hayes PD, Varty K.
Endovascular stenting versus open surgery for thoracic aortic disease:
systematic review and meta-analysis of perioperative results. J Vasc Surg
2008;47:1094—8.
[17] Taylor CL, Selman WR, Ratcheson RA. Steal affecting the central nervous
system. Neurosurgery 2002;50:679—88.
[18] Anyanwu A, Spielvogel D, Griepp RB. Spinal cord protection for descend-
ing aortic surgery. Clinical and scientific basis for contemporary surgical
practice. In: Rousseau H, Verhoye JP, Heautot JF, editors. Thoracic aortic
diseases. Berlin: Springer; 2006. p. 81—101.
[19] Horlocker TT, Wedel DJ, Benzon H, Brown DL, Enneking FK, Heit JA,
Mulroy MF, Rosenquist RW, Rowlingson J, Tryba M, Yuan CS. Regional
anesthesia in the anticoagulated patient: defining the risks (the second
ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagula-
tion). Reg Anesth Pain Med 2003;28:172—97.
Appendix A. Conference discussion
Dr A. Pavie (Paris, France): You undertook perioperatively a visual re-
routing aortic arch procedure on 16 patients of your series. I assume that no
patient had cerebral vascular accident after that?
Dr Gottardi: No, we didn’t see any.
Dr Pavie: Okay. In this subgroup of patients who had the re-routing
procedure before the operation, how many of them had paraplegia after that?
Because you don’t say in your paper in which group the paraplegia accident
occurs.
Dr Gottardi: Actually, right now, I’m not sure about the numbers. But as I
remember, there were also patients with paraparesis that underwent prior re-
routing procedures.
Dr Pavie: You said that you don’t drain systematically the CSF leakage due
to risk of haemorrhage and after that during the implantation of the device. At
the opposite, you said when you have spinal cord injury you drain
systematically. You define in a slide (not in your manuscript) a subgroup of
high risk of spinal cord accident. Why don’t you use systematically in this
subgroup cerebrospinal drainage for this type of patient?
Dr Gottardi: I completely agree with you, and you’re completely right that
CSF drainage carries a certain amount of risk. And our conclusion from this
study, this is what we learned when we were reviewing our data and looked at
it, and that’s how this study also will change our policies. So what we did in the
beginning, we had in the beginning lots of patients who required this stent-
graft placement of the entire aorta and there we had many patients who were
on continuing antiaggregatory therapy. That’s why we didn’t want to routinely
apply CSF drainage. As you can see, we have 21 patients where we don’t need
it. So I think it’s justified.
And we found out when we were reviewing the data that if you have two or
more vascular beds occluded, these are now high-risk patients where we will
do preoperative CSF drainage. If it’s only the intercostal arteries that will be
occluded, we don’t see any necessity in doing it.
Dr Pavie: But in the subgroup it seems logical.
Dr Gottardi: In the subgroup, yes, it’s justified.
Dr F. Bilgen (Istanbul, Turkey): In your study you have seen paraparesis in 5
cases.
Dr Gottardi: Yes.
Dr Bilgen: And your previous abdominal aneurysm operation ratio is 23%. Is
that right?
Dr Gottardi: Yes.
Dr Bilgen: Is there any relation between these two?
Dr Gottardi: Yes. It’s related, all our symptomatic patients had previously
undergone infrarenal aortic replacement and had occluded lumbar arteries.
Dr L. von Segesser (Lausanne, Switzerland): In our experience we sum it
up as the more Dacron, the higher the risk.Dr E. Weigang (Mainz, Germany): I come to the same conclusion, but my
protocol is more aggressive. We use CSF drainage routinely for every thoracic
and thoraco-abdominal stent-graft procedure, and we have used it in more
than a hundred cases now. You need someone, either an anaesthesiologist or a
neurologist, to insert the CSF drainage. We have observed no complications
with CSF drainage so far, and so I would recommend using it more frequently. I
would also recommend increasing the blood pressure after your stent-graft
deployment to more than 80. I personally increase the MAP up to 100 mmHg.
Dr Gottardi: I totally agree with you that we perhaps could raise blood
pressure a little bit higher, but 80 mmHg is our cutoff pressure. Sometimes it’s
also higher, up to 90, but 80 is our lowest acceptable mean arterial pressure of
the stent-graft placement.
Dr von Segesser: What about the patients with Plavix and aspirin in your
group?
Dr Weigang: We do not use CSF drainage if the patients are taking
clopidogrel.
Dr Czerny: But these are the patients we are talking about.
Dr Gottardi: And the rate of complications is given in the literature. Major
complications with haemorrhage and infection is given up to 5% and also
mortality associated with CSF drainage up to 0.6%. So I agree with you, if it’s
necessary you should use it; but we don’t think that it’s good to use it on a
routine basis if you don’t have to use it.
Dr Weigang: If we are talking about acute cases on therapy with
clopidogrel, I totally agree. But for the routine cases not on anti-platelet
therapy, I would be a bit more aggressive with the CSF drainage indication.
Dr C. Padmanabhan (Coimbatore, India): Do you have any experience on
neuromonitoring during these procedures, like an MEP or something? And if so,
whether it would help identify the subgroup of patients whom you say is high
risk so that the drainage can be instituted at an early point in time?
Dr Gottardi: No, we don’t use any neuromonitoring during the procedures,
especially as most of the problems don’t occur immediately but will come after
24 hours or so. So it’s not an immediate onset of symptoms, they will occur a
little bit later. So it would not make sense, to our understanding, to use routine
neuromonitoring during stent-graft placement. And if you extubate them
immediately, or at least superficialise anaesthesia, that you can see if they can
move the legs, I think that that’s sufficient.
Dr Padmanabhan: So you think it’s not required as a routine thing?
Dr Gottardi: In our setting, we don’t have it. And I think we have good
results without it, so I wouldn’t recommend it.
Dr R. Cartier (Montreal, Quebec, Canada): Did you have any delayed
paraplegia in the 5 symptomatic patients? And how long did it take to get the
reversal of the paraplegia in those that responded to the CSF drainage?
Dr Gottardi: Paraplegia or paraparesis occurred between 12 and 48 hours
after stent-graft placement and resolved within 12 hours, or 6 to 12 hours,
after initiation of CSF drainage.
Dr Cartier: And it was initiated right at the beginning of the symptoms.
Dr Gottardi: Yes, at the beginning of the symptoms.
Dr Cartier: So those patients all woke up with no symptoms?
Dr Gottardi: Yes. All were extubated immediately at the operating table
and could move a little bit the legs and symptoms occurred later.
Dr J. Bachet (Abu Dhabi, United Arab Emirates): The more and more we
see papers and presentations of this kind, the more and more we hear about
paraparesis cases as compared to paraplegia cases. And I’m wondering
whether this is not a way to reduce our guilt in front of this terrible
complication.
So I would like to know, what is your definition of paraparesis? If a patient
awakes and tries to stand up and can’t stand up, he’s paraplegic. How do you
make the difference between those two kinds of complications?
Dr Gottardi: As a matter of fact, I can’t give you an exact definition as it
would stand in a medical textbook. For us, the difference is with paraplegia he
can’t move anything, and with paraparesis there is still some motor function
left. And the one patient who has persistent neurologic deficit from
paraparesis, he has a weakness in the left leg. So on the right leg he’s able
to stand and walk, on the left leg it’s a little bit weaker.
Dr Bachet: Sorry. In the patient this is irrelevant. If a patient has a
weakness in one leg only, this is monoplegia. This has nothing to do with the
spinal cord. This is neurology.
Dr von Segesser: We are in the wrong session.
